Skip to main content

Articles

Page 1 of 92

  1. Chronic kidney disease (CKD) and osteoarthritis (OA) represent two frequently seen disorders among the general population, and they share several similar risk factors. The present work focused on assessing the...

    Authors: Kuiliang Gao, Chao Zhang, Yifan Zhang, Longyao Zhang, Jiankang Xu, Hongfei Xue, Lingling Jiang and Jinwei Zhang
    Citation: BMC Nephrology 2024 25:236
  2. Determining whether a patient is eligible for kidney transplantation is complex. In this study, we estimate what proportion of patients with end-stage kidney disease (ESKD) might have been suitable candidates ...

    Authors: Jessica L. Harding, Meredith A. Dixon, Mengyu Di, Julien Hogan, Stephen O. Pastan and Rachel E. Patzer
    Citation: BMC Nephrology 2024 25:235
  3. A percutaneous kidney biopsy (PKB) allows nephrologists to make informed decisions for treating various kidney diseases; however, the risk of bleeding complications should be considered, given the vascularity ...

    Authors: Hiroyasu Goto, Yota Kobayashi, Hiroki Sato, Tsugumi Fukunaga, Keiko Tanoue, Aoi Yamashiro, Hidehito Matsubara and Naoki Oshima
    Citation: BMC Nephrology 2024 25:234
  4. Glomerulonephritis (GN) is a leading cause of chronic kidney disease (CKD). Major adverse cardiovascular events (MACE) are prolific in CKD. The risk of MACE in GN cohorts is multifactorial. We investigated the...

    Authors: Elin Mitford Davies, Benjamin J. R. Buckley, Philip Austin, Gregory Y. H. Lip, Louise Oni, Garry McDowell and Anirudh Rao
    Citation: BMC Nephrology 2024 25:233
  5. Diabetes mellitus (DM) is a major public health concern with considerable morbidity and mortality. DM affects patients’ quality of life and can lead to multiple complications, including chronic kidney disease ...

    Authors: Jehad M. Zeidalkilani, Yazan A. Milhem, Reem N. Shorafa, Sari Taha, Amer A. Koni, Samah W. Al-Jabi and Sa’ed H. Zyoud
    Citation: BMC Nephrology 2024 25:232
  6. Diabetic kidney disease (DKD) is one of the most serious microvascular complications of diabetes mellitus (DM) and the leading cause of chronic kidney disease (CKD) worldwide. Since obesity and type 2 DM (T2DM...

    Authors: Asmaa Mounir Emara, Amal Said El Bendary, Laila Mahmoud Ahmed and Hanaa Ibrahim Okda
    Citation: BMC Nephrology 2024 25:231
  7. To evaluate the efficacy and safety of hydroxychloroquine sulfate (HCQ) in the treatment of low risk phospholipase A2 receptor (PLA2R)-associated membranous nephropathy (MN).

    Authors: Mei Mei, Jun Zeng, Zhengyang Liu, Li Gong, Li Fang, Quan Hu, Shaofen Huang, Liyin Chai, Xinqing Chen, Haili Sun, Sha Xiang, Chaolin Wen and Bingbing Shen
    Citation: BMC Nephrology 2024 25:230
  8. End-stage and acquired cystic renal disease (ESRD/ACRD) kidneys are characterized by inflammatory remodelling and multiplex renal cell carcinomas (RCC). Eosinophilic vacuolated tumour (EVT) occurs exclusively ...

    Authors: Tamas Beothe, Janos Docs, Gyula Kovacs and Lehel Peterfi
    Citation: BMC Nephrology 2024 25:227
  9. Contrast-induced acute kidney injury (CI-AKI) is an acute renal complication that occurs after intravascular contrast agent administration. Sodium selenite (SS) is an inorganic source of Se and has potent anti...

    Authors: Haiyan Xiang, Qianlin Tan, Yun Zhang, Yan Wu, Yaling Xu, Yuanhao Hong and Gen Li
    Citation: BMC Nephrology 2024 25:226
  10. Membranous nephropathy (MN) is a common type of nephrotic syndrome (NS) in adults, accounting for about 20–30% of cases. Although secondary to specific factors, the coexistence of MN and mantle cell lymphoma (...

    Authors: Bowen Qin, Yueqiang Li, Dong Kuang, Xi Yang, Chunyu Pan, Xiaojing Cai and Junhua Li
    Citation: BMC Nephrology 2024 25:225
  11. No reports have shown histological changes before and after anti-C5 monoclonal antibody treatment in patients with atypical hemolytic uremic syndrome (aHUS). Here, we report a rare case of complement-mediated ...

    Authors: Shigekazu Kurihara, Akinori Yamaguchi, Kosuke Sonoda, Yosuke Yamada, Makoto Harada, Koji Hashimoto, Hisashi Shimojo, Yoichiro Ikeda and Yuji Kamijo
    Citation: BMC Nephrology 2024 25:224
  12. Acute kidney injury (AKI) incidence is extremely high worldwide, and patients who develop AKI are at increased risk of developing chronic kidney disease (CKD), CKD progression, and end-stage kidney disease (ES...

    Authors: Yuma Hirano, Tomoyuki Fujikura, Kenichi Kono, Tomoya Yamaguchi, Naro Ohashi, Yurina Yokoyama, Masahiro Toda, Katsuya Yamauchi and Hideo Yasuda
    Citation: BMC Nephrology 2024 25:222
  13. Hemodialyzers should efficiently eliminate small and middle molecular uremic toxins and possess exceptional hemocompatibility to improve well-being of patients with end-stage kidney disease. However, performan...

    Authors: Götz Ehlerding, Wolfgang Ries, Manuela Kempkes-Koch, Ekkehard Ziegler, Petra Ronová, Mária Krizsán, Jana VereÅ¡ová, Mária Böke, Ansgar Erlenkötter, Robert Nitschel, Adam M. Zawada, James P. Kennedy, Jennifer Braun, John W. Larkin, Natalia Korolev, Thomas Lang…
    Citation: BMC Nephrology 2024 25:220
  14. Regional citrate anticoagulation (RCA) is recommended during continuous renal replacement therapy. Compared to systemic anticoagulation, RCA provides a longer filter lifespan with the risk of metabolic alkalos...

    Authors: Thomas Dimski, Timo Brandenburger, Christian Vollmer and Detlef Kindgen-Milles
    Citation: BMC Nephrology 2024 25:218
  15. The etiology of nephrotic syndrome can vary, with underlying metabolic diseases being a potential factor. Cobalamin C (cblC) defect is an autosomal recessive inborn error of metabolism caused by mutations in the

    Authors: Halil Tuna Akar, Harun Yıldız, Zeynelabidin Öztürk, Deniz Karakaya, Abdullah Sezer and Asburçe Olgaç
    Citation: BMC Nephrology 2024 25:217
  16. The contribution of chronic kidney disease (CKD) towards the risk of developing cardiovascular disease (CVD) is magnified with co-existing type 1 or type 2 diabetes. Lipids are a modifiable risk factor and goo...

    Authors: Sagen Zac-Varghese, Patrick Mark, Steve Bain, Debasish Banerjee, Tahseen A. Chowdhury, Indranil Dasgupta, Parijat De, Damian Fogarty, Andrew Frankel, Gabrielle Goldet, Janaka Karalliedde, Ritwika Mallik, Rosa Montero, Adnan Sharif, Mona Wahba, Ketan Dhatariya…
    Citation: BMC Nephrology 2024 25:216
  17. Live donor kidney transplantation is the preferred kidney replacement therapy for eligible patients but requires thorough donor evaluation to minimise risks. Contemporary guidelines recommend split kidney func...

    Authors: Joseph Sturman, Anthony Fenton, Usman Hayat, Robert Jones and Graham Lipkin
    Citation: BMC Nephrology 2024 25:214
  18. Certain occupations may predispose individuals to urolithiasis, a multi-factorial disease. The study aimed to evaluate the prevalence and related factors of nephrolithiasis in medical staff in Qingdao, China.

    Authors: Lei Guo, Lijun Liu, Ying Sun, Li Xue, Xingji Gong, Yue Wang, Wei Jiao and Haitao Niu
    Citation: BMC Nephrology 2024 25:213
  19. Sarcoidosis is a multisystemic inflammatory disease, characterized by the presence of non-caseating, epithelioid granulomas. Glomerular disease in patients with sarcoidosis is rare and membranous nephropathy (...

    Authors: Ying Ding, Yao Yao, Li Wan, Zhen Qu and Feng Yu
    Citation: BMC Nephrology 2024 25:212
  20. Salt intake in CKD patients can affect cardiovascular risk and kidney disease progression. Twenty-four hour (24h) urine collections are often used to investigate salt metabolism but are cumbersome to perform. ...

    Authors: Johanna T. Kurzhagen, Stephanie Titze, Beatrix Büschges-Seraphin, Mario Schiffer, Markus P. Schneider, Kai-Uwe Eckardt and Karl F. Hilgers
    Citation: BMC Nephrology 2024 25:210
  21. Autosomal recessive polycystic kidney disease (ARPKD) is a rare inherited cystic disease characterized by bilateral renal cyst formation and congenital liver fibrosis. Cardiovascular disorders such as noncompa...

    Authors: Weiran Zhou, Qingxia Du, Qinghua Liu, Xiaofang Liu, Lei Li and Hongxia Zhang
    Citation: BMC Nephrology 2024 25:209
  22. There is still a very high morbidity and mortality rate for patients undergoing peritoneal dialysis (PD). The advanced lung cancer inflammation index (ALI) has been demonstrated to be associated with the progn...

    Authors: Zhouhao Ren, Jiaying Wu, Shaorui Wu, Mengwei Zhang and Shuijuan Shen
    Citation: BMC Nephrology 2024 25:208
  23. Self-efficacy of patients on hemodialysis is considered a main component of the successful management of chronic kidney diseases. The self-efficacy of these patients may be influenced by many individual and so...

    Authors: Farzaneh Safi, Hossein Namdar Areshtanab, Mansour Ghafourifard and Hossein Ebrahimi
    Citation: BMC Nephrology 2024 25:207
  24. Tubular biomarkers, which reflect tubular dysfunction or injury, are associated with incident chronic kidney disease and kidney function decline. Several tubular biomarkers have also been implicated in the pro...

    Authors: Wei Wang, Zhiying You, Cortney N. Steele, Berenice Gitomer, Michel Chonchol and Kristen L. Nowak
    Citation: BMC Nephrology 2024 25:206
  25. The concomitant occurrence of membranous nephropathy and anti-glomerular basement (anti-GBM) disease has been previously described but is extremely rare. However, delayed recognition or misdiagnosis leads to d...

    Authors: Ge Liu, Xinyan Feng, Shuangyan Yu, Jie Sheng, Chunyan Liu and Lihua Wang
    Citation: BMC Nephrology 2024 25:204
  26. The complement factor 5 (C5)-inhibitor eculizumab has been established as standard-of-care for the treatment of atypical hemolytic uremic syndrome (aHUS). In 2021, the long-acting C5-inhibitor ravulizumab was ...

    Authors: Kristina Schönfelder, Lucas Kühne, Lena Schulte-Kemna, Jessica Kaufeld, Hana Rohn, Andreas Kribben, Bernd Schröppel, Paul T. Brinkkötter and Anja Gäckler
    Citation: BMC Nephrology 2024 25:202
  27. There is no evidence to determine the association between the lactate dehydrogenase to albumin ratio (LAR) and the development of sepsis-associated acute kidney injury (SAKI). We aimed to investigate the predi...

    Authors: Yipeng Fang, Yuan Zhang and Xin Zhang
    Citation: BMC Nephrology 2024 25:201
  28. Malakoplakia is a rare inflammatory disorder believed to result from a defect in macrophage phagocytic function triggering a granulomatous reaction. It can present with genitourinary, gastrointestinal, or cuta...

    Authors: Ayotola Fatola, Benjamin C. Johnson, Laura Walsh, Diana Fang, Marissa J. White, Dustin Le, Mohamed G. Atta, C. John Sperati and David N. Hager
    Citation: BMC Nephrology 2024 25:200
  29. Authors: Meihe Li, Xiaojun Hu, Yang Li, Guozhen Chen, Chen-guang Ding, Xiaohui Tian, Puxun Tian, Heli Xiang, Xiaoming Pan, Xiaoming Ding, Wujun Xue and Jin Zheng
    Citation: BMC Nephrology 2024 25:199

    The original article was published in BMC Nephrology 2024 25:138

  30. Sarcoidosis is a systemic disease that can affect multiple organs. While pulmonary sarcoidosis is most commonly observed, renal sarcoidosis occurs less frequently. We herein report a case of sarcoidosis with a...

    Authors: Shuhei Kitamoto, Mai Kaneko, Kyosuke Omata, Takashi Matsuyama, Hideo Yasuda, Ryuichi Furuya and Hirotaka Fukasawa
    Citation: BMC Nephrology 2024 25:198
  31. Hyperphosphatemia is associated with increased morbidity and mortality in patients with end-stage kidney disease (ESKD). Whereas clinical and observational studies have demonstrated the effectiveness of sucrof...

    Authors: Kamyar Kalantar-Zadeh, Linda H. Ficociello, Meijiao Zhou and Michael S. Anger
    Citation: BMC Nephrology 2024 25:197
  32. Acute kidney injury (AKI) is a common and serious condition, particularly among elderly patients. It is associated with high morbidity and mortality rates, further compounded by the need for continuous renal r...

    Authors: Xiang Li, Yang Li, Cheng-Juan Fan, Zhan-feng Jiao, Yi-Ming Zhang, Na-na Luo and Xiao-Fen Ma
    Citation: BMC Nephrology 2024 25:195
  33. Early identification of high-risk individuals with cisplatin-induced nephrotoxicity (CIN) is crucial for avoiding CIN and improving prognosis. In this study, we developed and validated a CIN prediction model b...

    Authors: Jingwei Zhang, Xuyang Luo, Yi Fan, Wei Zhou, Shijie Ma, Yuwei Kang, Wei Yang, Xiaoxia Geng, Heping Zhang and Fei Deng
    Citation: BMC Nephrology 2024 25:194
  34. Obesity is an important risk factor for kidney stones(KS). Chinese Visceral Adiposity Index (CVAI), as a specific indicator for visceral obesity in the Chinese population, can more accurately assess the viscer...

    Authors: XiXuan Cai, MingYing Xu, Liangli Chen, YiLin Huang, KeQing Shen, JieRu Chen, LuSha Li, Jianjiang Pan, Tao Chen and Liying Chen
    Citation: BMC Nephrology 2024 25:193
  35. Contrast media (CM) is a commonly applied drug in medical examination and surgery. However, contrast-induced acute kidney injury (CIAKI) poses a severe threat to human life and health. Notably, the CUT-like ho...

    Authors: Rong-Zheng Yue, Jing Wang, Feng Lin, Cong-Jun Li, Bai-Hai Su and Rui Zeng
    Citation: BMC Nephrology 2024 25:192
  36. Chronic kidney disease (CKD) is a global health problem with rising prevalence, morbidity, mortality, and associated costs. Early identification and risk stratification are key to preventing progression to kid...

    Authors: Murilo Guedes, Paulo Telles Dias, Rosângela R. Réa, Viviane Calice-Silva, Marcelo Lopes, Andrea Araujo Brandão, Andrea Carla Bauer, Andreza Almeida Senerchia, Pedro Túlio Monteiro de Castro e Abreu Rocha, Bruno Bezerra Rosa, Cinthia Montenegro Teixeira and Roberto Pecoits-Filho
    Citation: BMC Nephrology 2024 25:191
  37. Some studies have found that the pathological formation of kidney stones is closely related to injury and inflammatory response. Behaviors such as dietary composition, physical activity, obesity and smoking ca...

    Authors: Rundong Song, Ke Wu, Minghai Ma, Lu Wang, Yunzhong Jiang, Jianpeng Li and Jinhai Fan
    Citation: BMC Nephrology 2024 25:190
  38. Long-term enzyme replacement therapy (ERT) may improve prognosis in the patients with Fabry disease (FD), however, detail psychosocial burden has not been focused on long life expectancy. We experienced a male...

    Authors: Isao Ohsawa, Akiko Onuki, Fumie Oka, Yoshiyuki Matsuoka, Yuko Makita, Takashi Kobayashi, Yasuhiko Kanaguchi, Yuya Nakamura, Yusuke Suzuki, Yoshikazu Goto and Hiromichi Gotoh
    Citation: BMC Nephrology 2024 25:188
  39. This study examines medication adherence among kidney transplant patients at St. Paul’s Hospital Millennium Medical College (SPHMMC) in Addis Ababa, Ethiopia, focusing on the level of adherence and associated ...

    Authors: Meskerem Nimani Derejie, Erimas Nimane Dereje, Dirijit Mamo Alemu, Yemane Gebremedhin Tesfay, Fufa Hunduma and Negash Miniwye Temie
    Citation: BMC Nephrology 2024 25:187

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.2
    5-year Journal Impact Factor: 2.6
    Source Normalized Impact per Paper (SNIP): 0.907
    SCImago Journal Rank (SJR): 0.697

    Speed 2023
    Submission to first editorial decision (median days): 22
    Submission to acceptance (median days): 158

    Usage 2023
    Downloads: 3,053,628
    Altmetric mentions: 3,742

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal